Iron chelation therapy in patients with myelodysplastic syndromes: consensus conference guidelines.
Mittelman
Moshe
M
Department of Medicine, Tel Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel. moshemt@tasmc.health.gov.il
Lugassy
Gilles
G
Merkel
Drorit
D
Tamary
Hannah
H
Sarid
Nadav
N
Rachmilewitz
Eliezer
E
Hershko
Chaim
C
D000740:Anemia / Q000209:etiology / Q000628:therapy; D005293:Ferritins / Q000097:blood; D006801:Humans; D007501:Iron / Q000097:blood; D007502:Iron Chelating Agents / Q000627:therapeutic use*; D019190:Iron Overload / Q000188:drug therapy* / Q000209:etiology; D009190:Myelodysplastic Syndromes / Q000150:complications*; D018579:Patient Selection; D065227:Transfusion Reaction
D007502:Iron Chelating Agents; D005293:Ferritins; D007501:Iron